Skip to main content
. 2021 Apr;73(2):679–728. doi: 10.1124/pharmrev.120.000020

Fig. 4.

Fig. 4.

Steady-state plasma concentrations of colistimethate (A) and formed colistin (B) across a dosage interval in 215 critically ill patients. Patients were receiving colistimethate every 8, 12, or 24 hours. Each symbol represents the data from an individual. Permission obtained from Oxford University Press (Nation et al., 2017).